- Home
- ABEO vs SBT Comparison
ABEO vs SBT Comparison
Compare ABEO & SBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- SBT
- Stock Information
- Founded
- ABEO N/A
- SBT 1984
- Country
- ABEO United States
- SBT United States
- Employees
- ABEO N/A
- SBT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- SBT Savings Institutions
- Sector
- ABEO Health Care
- SBT Finance
- Exchange
- ABEO Nasdaq
- SBT Nasdaq
- Market Cap
- ABEO 247.8M
- SBT 253.2M
- IPO Year
- ABEO 1980
- SBT 2017
- Fundamental
- Price
- ABEO $5.70
- SBT $4.77
- Analyst Decision
- ABEO Strong Buy
- SBT
- Analyst Count
- ABEO 3
- SBT 0
- Target Price
- ABEO $18.00
- SBT N/A
- AVG Volume (30 Days)
- ABEO 229.2K
- SBT 30.0K
- Earning Date
- ABEO 11-14-2024
- SBT 01-22-2025
- Dividend Yield
- ABEO N/A
- SBT N/A
- EPS Growth
- ABEO N/A
- SBT N/A
- EPS
- ABEO N/A
- SBT 0.12
- Revenue
- ABEO N/A
- SBT $67,988,000.00
- Revenue This Year
- ABEO N/A
- SBT N/A
- Revenue Next Year
- ABEO $18,714.71
- SBT $6.68
- P/E Ratio
- ABEO N/A
- SBT $40.11
- Revenue Growth
- ABEO 147.52
- SBT N/A
- 52 Week Low
- ABEO $3.05
- SBT $4.40
- 52 Week High
- ABEO $9.01
- SBT $5.97
- Technical
- Relative Strength Index (RSI)
- ABEO 34.30
- SBT 45.25
- Support Level
- ABEO $5.45
- SBT $4.71
- Resistance Level
- ABEO $6.04
- SBT $4.87
- Average True Range (ATR)
- ABEO 0.19
- SBT 0.04
- MACD
- ABEO -0.04
- SBT -0.01
- Stochastic Oscillator
- ABEO 19.47
- SBT 37.50
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About SBT Sterling Bancorp Inc.
Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.